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The objective of the study is to examine the role of characteristics of proteins in maternal
and weaning diets on risk of metabolic syndrome in male offspring.
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Objective

Methods
Pregnant Wistar rats were allocated to two groups (n = 12) and were fed the AIN-93G diets based on either intact protein-based diet (IPD) or mixed amino acid-based diet (AAD)
from day 3 of gestation throughout gestation and lactation. Male offspring were weaned
to either an IPD or AAD diet for 18 weeks.

Results
In dams, AAD group had lower body weight in post-partum period and higher pulse rate
compared with IPD group. In pups born to AAD dams, birth weight and body weight were
significantly lower, and systolic blood pressure and fasting blood glucose were significantly higher compared with those born to IPD dams. Fat/weight ratio, insulin and homeostasis model assessment of insulin resistance were not influenced by either
maternal or weaning diet.

Conclusions
These results indicate that the physico-chemical structure of proteins fed to dams is important in altering risk factors of metabolic syndrome in the offspring, while weaning diets
do not seem to play a role. IPD had more favourable effect than AAD. These results may
also indicate that dietary recommendations during development must be updated based
on physiological properties of dietary proteins that are beyond their nutritional role.

Keywords: Amino acid, fetal programming, metabolic syndrome, protein.

Introduction
The prevalence of metabolic syndrome (MS) has reached
epidemic proportion (1). According to the National Health
and Nutrition Examination Survey, the prevalence of MS
in 2010 was 34% (2). The increasing prevalence of abdominal obesity, particularly among female adults has
been suggested as a major contributing factor to the
MS (2). The role of maternal diet during gestation and
the early postnatal period on the development of MS in
offspring has been previously demonstrated (3–5). Dietary
proteins fed during gestation, lactation or both influenced

the phenotype of offspring in humans and animals (6).
Both high-protein and low-protein maternal diets showed
detrimental effects on body weight (BW), blood pressure,
and metabolic and food intake regulatory systems in the
offspring (7–17). We have previously reported that pups
born to dams fed a soy protein-based diet had higher
BW, systolic blood pressure (SBP) and diastolic blood
pressure (DBP) and plasma insulin at week 14 postweaning (PW) compared with those born to dams fed a
casein-based diet (18). Food intake was also higher in offspring born to dams fed soy protein diet in PW period
(19). These data indicate that even in a nutritionally
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balanced diet fed during gestation and lactation, the
source of protein can influence the risk of MS in the offspring (18–20).
In spite of considerable evidence indicating the role of
maternal dietary proteins in developmental programming,
the underlying mechanisms are still elusive. In adults, dietary proteins elicit a wide range of nutritional and biological functions. They are involved in regulation of food
intake, glucose and lipid metabolism, blood pressure,
bone metabolism and immune function (8). Clearly, these
properties of proteins are far beyond their traditional
definition as a source of indispensable amino acids and
protein synthesis (8).
Proteins in weaning diets may also interact with maternal diet. Bautista et al. showed that offspring born to
dams fed a low protein diet and weaned to corn and soy
protein had lower weight and body fat percentage
compared with those born to dams fed a low protein diet
and weaned to a casein-based diet, indicating that the
source of protein in the weaning diet altered the
outcomes of maternal protein-restricted diets (21). The
source-dependent effect of proteins on developmental
programming supports the potential role of characteristics of individual proteins in their metabolic and
physiologic outcomes. Physico-chemical properties,
digestion kinetics, amino acid composition and bioactive
peptides (BAPs) encrypted in amino acid sequences of
proteins are proposed mechanisms (8). There is also a line
of evidence supporting the source-dependent effect of
proteins consumed during pregnancy and lactation on
the health of the offspring. Amino acids have their
individual effects during development, in addition to their
role in protein synthesis. For example, low protein diets
with similar protein content but different amounts of
methionine (Southampton diet has higher methionine
content compared with Hope farm diet) affect programming of blood pressure differently (6). Adding glycine to
the Southampton diet, which reduces plasma homocysteine, leads to normalization of blood pressure. This may
suggest that the methionine load is a contributor to
increased blood pressure in offspring (22). Moreover,
taurine supplementation can regulate insulin secretion
and promote insulin sensitivity. Taurine can also
ameliorate fructose-induced hyperglycemia, hypertension and hepatic steatosis in pregnant and non-pregnant
rats (23).
Many physiological functions of proteins are attributed to their BAPs (24). For example, BAPs inhibit angiotensin converting enzyme, which lowers blood pressure in
experimental animals (25). Casomorphins are one of the
major groups of BAPs that are abundant in casein and
affect food intake regulation, gastrointestinal (GI)
movement and plasma insulin concentrations (26–28).
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However, whether BAPs contribute to the effect of
maternal proteins on phenotype of offspring is still
elusive.
Lastly, amino acid kinetics has also been suggested
as a reason for variations in their postprandial metabolic
effects. For example, casein is classified as a slow protein leading to delayed amino acid delivery to the gut,
because it precipitates under the acidic gastric pH, while
whey remains soluble and rapidly passes through the
stomach leading to a faster delivery of amino acids to
the circulation. Therefore, whey protein ingestion results
in larger increases in post-meal aminoacidemia than
casein and leads to a higher protein synthesis, whereas
casein has a greater effect on reducing protein breakdown (8).
The primary objective of this study was to examine the
hypothesis that characteristics of proteins (intact or
amino acid mixture) fed during gestation and lactation
play a role on the development of risk factors of MS in
the offspring. Additionally, to examine the potential main
and interactive effects of maternal and weaning diets,
our second objective was to determine the effect of
characteristics of proteins of the weaning diet on the outcomes of the maternal diet in the offspring.

Experimental methods
Animals and diets
First-time pregnant Wistar rats were received at day 3
of gestation (Charles River, NC, USA) and housed individually in ventilated plastic cages with bedding at
22  1 °C and 12-h light–dark cycle (lights off at 0900
to 2100 h). The diets were provided ad libitum in glass
jars. All rats had free access to water throughout the
experiments.
Diets (AIN-93G) were purchased from Dyets (Dyets Inc.
Bethlehem, Pa, USA). The composition (per kilogram diet)
of the diets is illustrated in Table 1. The amino acid composition of the intact protein (casein) and the amino acid
mix are illustrated in Table 2. The protocol was approved
by University of North Florida Institutional Animal Care
and Use Committee.

Experimental design
Newly pregnant Wistar rats (n = 24) were received at the
third day of pregnancy and were allocated to two groups
(n = 12 per group) and received either an amino acidbased diet (AAD) or an intact protein-based diet (IPD)
during pregnancy and lactation. BW of the dams was
measured weekly. BW of the pups was measured at birth
(day 1, after litters were culled to 10 pups per dam) and on
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Table 1 Composition of intact protein-based and amino acid-based
AIN-93G diets
Intact casein diet
Cal

Amino acid diet

3,597

3,811
g kg

Casein
Amino acid mix
Sucrose
Soybean oil
t-Butyhydroquinone
Cornstarch
Dyetrose
Cellulose
Mineral mix
Sodium bicorbonate
Vitamin mix
Choline bitartrate
L-Cystine

200
0
100
70
0
397.5
132
50
35
0
10
2.5
3

1

0
180
100
70
0.014
399.9
145
50
35
7.4
10
2.5
0

Table 2 Amino acid composition of intact protein-based and amino
acid-based AIN-93G diets
Intact casein diet

Amino acid diet
g kg

Alanine
Arginine
Aspartic acid
Cystine
Glutamic acid
Glycine
Histidine
Isoleucine
Leucine
Lysine
Methionine
Phenylalanine
Proline
Serine
Threonine
Tryptophan
Tyrosine
Valine

4.7
6.5
11.7
3.7†
37.5
3.2
4.7
8.6
15.9
13.3
4.7
9.0
21.1
9.7
6.8
2.2
9.6
10.3

1

4.5
6.3
11.3
3.7
36.2
3.1
4.5
8.4
15.3
16.1
4.5
8.7
20.4
9.4
6.6
2.1
9.2
9.9

The amino acid content of the diets is calculated based on purity of
the sources (87% and 99% for casein and amino acid mix,
respectively).
†
The addition of the free amino acids (L-cystine) to the intact proteinbased diet is included.

days 7, 14 and 21. At weaning (day 21 of age), one male
offspring from each dam on each maternal diet group
was assigned to either the AAD or IPD (n = 12 per group).
BW was measured weekly for 18 weeks after weaning.
SBP and DBP, pulse rate, fasting blood glucose (FBG)
and blood glucose (BG) response to a glucose load were
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measured at weeks 4, 8, 12 and 16 PW for the offspring
and were measured at week 6 PW for the dams. Fat pad
mass was measured at killing at week 6 PW for the dams
and at week 18 PW for offspring. Plasma glucose and insulin were measured at birth, weaning and at week 18 PW
for the offspring and were measured at week 6 PW for the
dams.

Glucose tolerance test
Rats were fasted overnight for 12 h. Blood samples were
drawn from the tail vein at fasting and at 15, 30 and
60 min after a glucose administration (0.375 g glucose
per mL, 5 g glucose per kg BW) (18).

Blood pressure
Systolic blood pressure and DBP were measured by a
non-invasive tail-cuff method (optical plethysmography)
using a tail manometer tachometer system (BP-2000,
Visitech system; Apex, NC, USA). Rats were restrained
in holders on a constant warm platform (30 °C). They were
adapted daily to the procedure for 5 d. On the day of
measurement, five mock measurements preceded a series of ten measurements that were used to calculate
the average as reported previously (18).

Blood glucose
Tail vein glucose concentration was assayed using a
handheld commercial glucometer (Contour ® Next Blood
Glucose Meter, Bayer Healthcare LLC, Mishawaka, IN,
USA) using test strips. The accuracy and variance of the
glucometer and test strips were examined by applying
control solutions (levels 1 and 2) provided by the
manufacturer (Bayer, Bayer Healthcare LLC, Mishawaka,
IN, USA) (18).

Blood collection
As previously described (18), trunk blood was collected in
chilled vacutainer tubes (BD, Franklin Lakes, NJ, USA)
containing EDTA + Trasylol ® (Bayer AG, Leverkusen,
Germany) solution (10% blood volume, 5 × 108 IU L).
Thereafter, blood samples were centrifuged at 3,000 g
and 4 °C for 10 min. Plasma was separated and immediately stored at 70 °C.

Hormone assays
Plasma insulin concentrations were measured using
enzyme-linked immunosorbent assay (catalogue no. 80-

© 2017 The Authors
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INSRT-E01, Alpco Diagnostics, Salem, NH, USA) with
assay sensitivity of 0.124 ng mL 1.
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Results
Dams

Body composition
Fat mass and lean mass were measured right after killing
at weeks 6 and 18 PW for dams and pups, respectively.
Fat mass was measured by dissection of extracted abdominal, epididymal and perirenal fat (18).

Statistical analyses
The effect of the maternal and weaning diets and their
interactions on BW, glucose response, SBP and DBP
was analysed by two-way analysis of variance. When
repeated measures were made over time on BW, food
intake, SBP, DBP, pulse, BG response and FBG, the
PROC MIXED procedure was used with maternal diets,
weaning diets and time as main factors. When interactions were statistically significant, a one-way analysis
of variance followed by post hoc Tukey’s test was conducted to evaluate treatment effects. The effects of the
maternal diets on plasma measures were compared by
using a Student’s unpaired t-test. BG response was calculated as the total incremental area under the curve
(tAUC) of the BG concentration over 1 h after receiving
glucose administered for the glucose tolerance test. The
homeostasis model assessment of insulin resistance index was calculated as fasting glucose multiplied by
fasting insulin divided by 22. Data are expressed as
means with standard errors. Statistical significance was
defined at P < 0.05. All analyses were conducted using
SAS (version 9.4; SAS Institute, Cary, NC, USA).

Body weight was affected by the diet after parturition,
during lactation and at weeks 2, 5 and 6 PW and was
higher in dams fed the IPD (P < 0.05) (Figure 1). However,
no difference in fat/weight percentage at week 6 PW was
observed (Table 3). No effect of the diet on SBP and DBP
was observed (data not shown), but pulse rate was higher
in the AAD group compared with the IPD group
(443.64  9.79 vs. 412.99  8.49, respectively)
(P < 0.005). No effect of the maternal diet on FBG, BG
response, homeostasis model assessment of insulin resistance or insulin/glucose ratio was observed (Table 4).

Pups
Birth weight was altered by maternal diet. It was higher in
pups born to dams fed IPD (P < 0.05) (Table 3). BW was
also higher at weeks 13 to 18 PW in pups born to dams
fed IPD (P < 0.009) (Figure 2). Moreover, weaning diet
had a relatively significant effect on BW (P = 0.06): Pups
fed the IPD had relatively higher BW compared with those
fed the AAD. DBP was altered by maternal diet: It was
higher in pups born to dams fed the AAD compared with
those born to dams fed the IPD (P < 0.04) (Table 5).
SBP was also relatively higher in pups born to dams fed
the AAD (P = 0.06) (Table 5). No effect of either maternal
or weaning diet on pulse rate was observed. FBG was
also altered by the maternal diet: It was higher in pups
born to dams fed the AAD compared with those born to
dams fed the IPD (P < 0.01) (Table 6). BG response to

Figure 1 Effect of maternal diet on dams’ body weight (n = 12 per group). Data are means  standard error of the mean; body weight was analyzed by one-way analysis of variance. *P < 0.05; AAD, amino acid-based diet; IPD, intact protein-based diet.
© 2017 The Authors
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Table 3 Effect of maternal diet on body weight, fat and fat% in dams
at week 9 post-partum and offspring at birth, weaning and at week 18
post-weaning
Maternal diet

IPD

AAD

Dams (week 9 post-partum)
Body weight (g)
300.49  9.45 273.95  7.12
Fat* (g)
21.7  0.86
18.69  0.98
Fat/weight ratio (%)
7.03  0.22
6.80  0.26
Pups
At birth
Body weight (g)
6.34  0.08
6.06  0.09
At weaning
Body weight (g)
55.99  1.24
48.41  1.05
Fat (g)
4.81  0.16
4.23  0.3
Fat/weight ratio (%)
8.63  0.30
8.90  0.62
At wk 18 PW
Body weight (g)
526.70  11.81 475.89  11.49
Fat (g)
20.32  0.95
18.75  0.87
Fat/weight ratio (%)
3.83  0.13
3.94  0.15

Obesity Science & Practice

Table 4 Effect of maternal diet fed during gestation and lactation on
FBG, fasting plasma insulin, I/G ratio in dams at week 9 post-partum
and in offspring at birth, weaning and at week 18 post-weaning
(n = 5–6 per group)

P
Maternal diet
P < 0.05
NS
NS

P < 0.05
P < 0.05
NS
NS
P < 0.05
NS
NS

Data are means  SEM.
*Fat was calculated by sum of abdominal, epididymal and perirenal fat.
AAD, amino acid-based diet; IPD, intact protein-based diet; PW,
post-weaning; SEM, standard error of the mean.

glucose also approached significance in pups born to
dams fed the AAD (P = 0.06) (Table 6).

Discussion
The results of this study support the hypothesis that characteristics of proteins fed during gestation and lactation play a
dominant role in their effect on the dams and their offspring’s
phenotype. These results also suggest that the sourcedependent effect of proteins, as previously reported by us
(18–20), can be due to individual characteristics of proteins.
The significance of the interaction of the chemical and
physical structure of dietary proteins with the regulation
of metabolism and food intake has received considerable
attention in the past 15 years (8). The primary focus of the
majority of the studies has been on understanding the
role of amino acid composition and sequence, BAPs
encrypted in protein’s structure, digestion kinetics and
also non-protein components conjugated with proteins
(e.g. calcium and phosphorous content of casein) as potential factors determining the metabolic and physiologic
functions of proteins (8).
In this study, the difference between amino acid composition and content of AAD and IPDs is negligible
(Table 2) with the exception of lysine that was 20% higher
in AAD diet compared with IPD diet. However, to the best
of our knowledge there is no evidence indicating the effect of lysine on measured parameters in this study.
Therefore, our findings cannot be attributed to individual
amino acids or amino acid composition of the diets.

IPD

Dams (Wk 9 postpartum)
Glucose, mM
5.31  0.28
Insulin, ng/ml
2.28  0.43
I/G Ratio
0.48  0.14
HOMA-IR*
0.55  0.03
OGTT (Wk 4 pp) 533.31  21.54
Pups
At birth
Glucose, mM
5.25  0.78
Insulin, ng/ml
1.13  0.30
I/G Ratio
0.23  0.06
HOMA-IR
0.24  0.09
At weaning
Glucose, mM
5.41  0.50
Insulin, ng/ml
1.66  0.06
I/G Ratio
0.33  0.03
HOMA-IR
0.38  0.04
At wk 18 PW
Glucose, mM
4.64  0.15
Insulin, ng/ml
2.17  0.42
I/G Ratio
0.45  0.09
HOMA-IR
0.42  0.85

AAD

P

4.90  0.28
2.35  0.65
0.58  0.09
0.55  0.00
444.84  17.47

NS
NS
NS
NS
P < 0.004

5.36
1.18
0.22
0.26






0.38
0.14
0.01
0.05

NS
NS
NS
NS

4.88
1.91
0.34
0.31






0.56
0.24
0.04
0.03

NS
NS
NS
NS

5.52
3.32
0.61
0.72






0.20
0.10
0.21
0.24

P < 0.05
NS
NS
NS

Data are means  SEM.
*HOMA-IR index was calculated as fasting glucose (mM) multiplied
1
by fasting insulin (ng mL ) divided by 22.5.
AAD, maternal amino acid-based diet; G, glucose; HOMA-IR,
homeostatic model of assessment insulin resistance; I, insulin; IPD,
maternal intact protein-based diet; NS, not significant; PP, postpartum; PW, post-weaning; SEM, standard error of the mean.

Moreover, these results must be interpreted based on
the fact that both diets were standardized (AIN-93 Gbased diets, and therefore, they are nutritionally adequate
and balanced. However, the difference in digestion kinetics and also BAPs encrypted in casein (the sole source of
protein in IPD) are potential factors that may play a determining role in outcomes of this study.
As previously described, the difference in amino acid
kinetics may result in variations in postprandial metabolic
and physiologic response to proteins (29,30). Casein is
classified as a slow protein and therefore delays amino
acid delivery to the gut, while free amino acids released
from AAD will be absorbed at a much faster pace compared with amino acids trapped in intact casein. This
quick absorption of amino acids may have a negative impact on amino acid utilization and protein synthesis in the
post-absorptive stage (8). For example, rapid digestion
and absorption of soy protein resulted in a larger portion
of amino acid degradation and consequently, less protein
synthesis compared with casein (31). It may explain, at

© 2017 The Authors
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Figure 2 Effect of maternal diet on post-weaning body weight of male offspring (n = 24 per group). Data are means  standard error of the
mean; body weight was analyzed by MIXED procedure with maternal diets and time as main factors. Time: P < 0.0001; maternal diet:
P < 0.009; weaning diet: P = 0.06. AAD, amino acid-based diet; IPD, intact protein-based diet.

Table 5 Effect of maternal and weaning diets on SBP, DBP and pulse in offspring at weeks 4, 8, 12 and 16 post-weaning
IPD
Maternal diet
Weaning diet
SBP

DBP

Pulse

IPD

AAD
AAD

IPD

AAD

P
M: P = 0.06
W: NS
T: P < 0.0001

Week
4
8
12
16

120.15
140.31
146.27
144.39

 2.94
 3.16
 3.83
 3.42

121.03
137.70
139.72
147.27






5.70
4.98
3.72
4.49

130.98
153.72
148.20
148.29






5.49
4.24
3.46
1.72

120.55
141.95
150.46
141.46






8.93
4.27
2.93
5.70

4
8
12
16

83.43
76.60
82.05
80.96

 5.44
 2.94
 4.83
 5.15

79.15
84.16
85.57
83.23






5.95
6.02
5.35
6.62

81.09
93.90
83.32
89.38






4.14
5.25
3.95
4.72

73.83
94.75
95.98
89.45






4.12
4.76
5.32
3.25

M: P < 0.04
W: NS
M × T: P < 0.04

4
8
12
16

450.29
435.73
438.72
427.53

 7.89
 6.65
 11.70
 9.04

458.99
440.94
427.99
427.63






9.86
12.02
11.14
14.10

448.06
474.25
438.43
440.47






15.12
7.92
9.06
14.50

456.93
440.89
449.39
453.83






17.74
8.94
9.82
11.20

M: NS
W: NS
T: NS

Data are means  SEM.
Different letters in each row are significantly different (P < 0.05).
AAD, amino acid-based diet; DBP, diastolic blood pressure; IPD, intact protein-based diet; M, maternal diet; NS, not significant; SBP, systolic
blood pressure; SEM, standard error of the mean; T, time; W, weaning diet.

least partially, lower lean mass and BW observed in dams
fed the AAD in this study. However, to our knowledge,
there is no study examining the role of proteins’ or amino
acids’ digestion kinetics on fetal programming.
Casein, as a major protein in bovine milk, is a micellar
phosphoprotein comprised by αs1-casein, αs2-casein,
β-casein and κ-casein and known as casein micelles.
Commercial preparation of κ-casein typically contains
about 5% of carbohydrates (w/w) (trisaccharides or
tetrasaccharides), consisting of N-acetylneuraminic
acid (sialic acid), galactose and N-acetylgalactosamine.

κ-casein is comprised of para-κ-casein (residues 1–105)
and caseinomacropeptide (residues 106–169), and its
glycosylated form glycomacropeptide (8). Casein also
contains substantial amount of phosphorous and calcium
in micellar form (8). Peptides produced during different
stages of digestion of casein may express a variety of
functions in the GI tract (32,33) including the regulation
of digestive enzymes, the modulation of nutrient absorption in the intestinal tract and also post-absorptive metabolic signals. For example, glycomacropeptide from κcasein suppresses protein hydrolysis by inhibiting gastric

© 2017 The Authors
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Table 6 Effect of maternal and weaning diets on FBG and BG in BG in response to glucose in offspring at weeks 4, 8, 12 and 16 post-weaning
(n = 6 per group)
IPD
Maternal diet
Weaning diet
FBG

OGTT

IPD
Week
4
8
12
16
4
8
12
16

AAD
AAD

5.27
4.95
5.70
5.87






0.24
0.13
0.20
a
0.25

484.86
466.18
439.58
501.74






20.87
32.71
23.54
a
55.46

IPD

5.68
5.45
4.77
4.73






0.33
0.48
0.14
b
0.17

516.88
487.57
439.51
469.31






19.86
20.00
11.26
a
47.17

AAD

5.97
5.58
5.20
5.09






0.41
0.30
0.12
a
0.24

5.60
5.91
5.48
5.95

453.33
445.92
438.58
377.08






6.97
19.89
19.11
b
9.76

540.14
467.71
455.97
516.32

P

 0.59
 0.26
 0.56
a
 0.22

M: P < 0.01
W: NS
T: P < 0.04
M × W: NS

 32.13
 20.24
 26.61
a
 22.52

M: NS
W: P = 0.06
T: P < 0.05
M × W: NS

Data are means  SEM.
Different letters in each row are significantly different (P < 0.05).
AAD, amino acid-based diet; BG, blood glucose; FBG, fasting blood glucose; IPD, intact protein-based diet; M, maternal diet; NS, not significant; OGTT, oral glucose tolerance test; SEM, standard error of the mean; T, time; W, weaning diet.

secretion and motility (34). The more favourable effect of
casein on blood pressure in this study can be attributed
to its BAPs as it is evidenced by the fact that hydrolysates
of proteins lower BP in both human and animals. Casein is
rich in casomorphins, one of the major groups of BAPs in
casein, capable of activating opioid receptors in the enteric
nervous system and on the vagus nerve, resulting in vasodilation and lowering blood pressure (35–37). Daily consumption of casein hydrolysate (0·49 g d 1) containing
the peptides valine–proline–proline and isoleucine–
proline–proline, lowered both SBP and DBP in hypertensive subjects (38). In addition, oral administration of casein hydrolysate (32 mg kg 1 BW per day) decreased
BP in hypertensive rats (39). Whether BAPs can cross the
placenta and alter fetal development directly or indirectly
by influencing maternal metabolism has not been shown.
In this study, administration of an intact protein-based
maternal diet resulted in lower FBG in offspring at week
18 PW (Table 4). The effect of proteins on glucose metabolism depends on amino acid composition, digestion
kinetics of proteins and amino acid utilization in the GI tract.
In general, when consumed with carbohydrates, dietary
proteins reduce glycemic response (40,41). This can be because proteins and BAPs delay gastric emptying resulting
in lower glucose absorption rate and glycemic response
(8). Moreover, postprandial elevation of plasma amino
acids stimulates the secretion of both insulin and glucagon (42,43) and, therefore, alters hepatic glucose metabolism by changing the portal insulin/glucagon ratio (44).
However, the ultimate change in plasma glucose levels
depends on the overall change in insulin/glucagon ratio.
Administration of the maternal AAD resulted in lower birth
weight compared with the IPD. Although this observation is

extremely important, the potential mechanisms by which
maternal AAD resulted in lower birth weight is unclear at
current. Low birth weight is associated with a higher risk
of metabolic diseases in adulthood, including type 2 diabetes, hypertension and dyslipidemia (45,46). It may explain
the higher SBP and DBP observed in offspring born to dams
fed AAD. However, lower birth weight observed in pups
born to dams fed AAD was followed by a rapid catch-up
growth during lactation, which is consistent with previous
studies (47–49). The negative impact on health of catchup growth followed by a low birth weight in later life is not
clear. In some studies, rapid weight gain in the early postnatal period had a negative impact on health later in life
(50–53), while other studies reported that low weight at
1 year of age or low weight gain in the first year of life increased the risk of developing metabolic and cardiovascular
disease later in life, independent of catch-up growth (54–59).
Birth weight has also been inversely associated with
truncal/peripheral fat ratio but not with relative body fat
at 6 months (60). This finding is consistent with our observation that in spite of lower BW in pups born to dams fed
AAD at week 18 compared with those born to dams fed
IPD, no difference in fat/weight % was observed.
Maternal diet had a predominant effect on various aspects of pups’ health in this study, while weaning diet
did not show any significant influence on measured outcomes. However, the effect of weaning diet on pups’
BW approached significance (P = 0.06). Interestingly,
AAD with relatively higher calorie density compared with
IPD (3,811 and 3,597 cal kg 1, respectively) resulted in
lower BW in both dams and offspring.
In summary, the results of this study for the first time
revealed that chemical and physical structure of proteins
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are dominant factors influencing growth and development
in both the fetal and neonatal periods. The finding that intact protein has more favourable effect on health of the
offspring highlights metabolic and physiologic functions
of proteins that are attributed to their physico-chemical
properties and are far beyond their traditional nutritional
role as a source of indispensable amino acids and
calories. Evidently, even though both AAD and IPD are
nutritionally complete diets, the molecular aspects of
proteins fed during pregnancy and lactation in animal
models of development could be a factor influencing the
phenotype of the offspring. However, this area of research is still in infancy, and much more research is
needed to understand the underlying mechanisms by
which proteins influence developmental programming.

Conclusions
Our results indicate that the physico-chemical structure
of proteins fed to dams is important in altering risk factors
of MS in offspring, while weaning diets do not seem to
play a role. Feeding a diet composed of intact protein (casein) to pregnant and lactating dams was more beneficial
than feeding a diet composed of amino acids regarding
risk factors of MS. These results also support the notion
that proteins exhibit many physiological functions beyond
their nutritional roles. Therefore, the current dietary and
clinical recommendations must be updated based on
new findings in the field of proteins particularly considering their role during development.

Conflict of Interest Statement

A. Jahan-mihan et al.

231

5. Barker DJ, Law CM. Birth weight and blood pressure in adolescence.
Studies may be misleading. BMJ Clin Res Ed 1994; 308: 1634.
6. Jahan-mihan A, Rodriguez J, Christie C, Sadeghi M, Zerbe T. The
role of maternal dietary proteins in development of metabolic syndrome in offspring. Nutrients 2015; 7: 9185–9217.
7. Lucas A. The developmental origins of adult health and well-being.
Adv Exp Med Biol 2005; 569: 13–15.
8. Jahan-mihan A, Luhovyy BL, el Khoury D, Anderson GH. Dietary
proteins as determinants of metabolic and physiologic functions of
the gastrointestinal tract. Nutrients 2011; 3: 574–603.
9. Zambrano E, Bautista CJ, Deas M, et al. Low maternal protein diet
during pregnancy and lactation has sex- and window of exposurespecific effects on offspring growth and food intake, glucose metabolism and serum leptin in the rat. J Physiol 2006; 571: 221–230.
10. Rees WD, Hay SM, Brown DS, Antipatis C, Palmer RM. Maternal
protein deficiency causes hypermethylation of DNA in the livers of
rat fetuses. J Nutr 2000; 130: 1821–1826.
11. Langley-Evans SC, Gardner DS, Jackson AA. Maternal protein restriction influences the programming of the rat hypothalamicpituitary-adrenal axis. J Nutr 1996; 126: 1578–1585.
12. Langley-Evans SC, Phillips GJ, Jackson AA. In utero exposure to
maternal low protein diets induces hypertension in weanling rats,
independently of maternal blood pressure changes. Clin Nutr (Edinb
Scotl) 1994; 13: 319–324.
13. Sasaki A, Nakagawa I, Kajimoto M. Effect of protein nutrition
throughout gestation and lactation ongrowth, morbidity and life span
of rat progeny. J Nutr Sci Vitaminol (Tokyo) 1982; 28: 543–555.
14. Zhang J, Wang C, Terroni PL, Cagampang FR, Hanson M, Byrne
CD. High-unsaturated-fat, high-protein, and low-carbohydrate diet
during pregnancy and lactation modulates hepatic lipid metabolism
in female adult offspring. Am J Physiol Regul Integr Comp Physiol
2005; 288: R112–R118.
15. Thone-Reineke C, Kalk P, Dorn M, et al. High-protein nutrition
during pregnancy and lactation programs blood pressure, food efficiency, and body weight of the offspring in a sex-dependent
manner. Am J Physiol Regul Integr Comp Physiol 2006; 291:
R1025–R1030.

The authors declared no conflicts of interest.

16. Beyer M, Jentsch W, Kuhla S, et al. Effects of dietary energy intake
during gestation and lactation on milk yield and composition of first,
second and fourth parity sows. Arch Anim Nutr 2007; 61: 452–468.

Funding

17. Daenzer M, Ortmann S, Klaus S, Metges CC. Prenatal high protein
exposure decreases energy expenditure and increases adiposity in
young rats. J Nutr 2002; 132: 142–144.

This study is supported by US Foundation, University of
North Florida, Brooks College of Health.

References
1. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal
KM. Prevalence of overweight and obesity among US children,
adolescents, and adults, 1999–2002. JAMA 2004; 291: 2847–2850.
2. Beltrán-Sánchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999–2010. J Am Coll Cardiol 2013; 62: 697–703.
3. Eriksson R, Olsson B. Adapting genetic regulatory models by
genetic programming. Biosystems 2004; 76: 217–227.
4. Adair LS, Kuzawa CW, Borja J. Maternal energy stores and diet
composition during pregnancy program adolescent blood pressure.
Circulation 2001; 104: 1034–1039.

18. Jahan-mihan A, Szeto M, Luhovyy B, Huot P, Anderson G. Soy
protein and casein based nutritionally complete diets fed during
gestation and lactation differ in effects on characteristics of metabolic syndrome in male offspring of wistar rat. Br J Nutr 2012; 107:
284–294.
19. Jahan-Mihan A, Smith C, Anderson GH. The effect of protein source
in diets fed during gestation and lactation on food intake regulation
in male offspring of Wistar rats. Am J Physiol Regul Integr Comp
Physiol 2011; 300: R1175–R1184.
20. Jahan-mihan A, Smith CE, Hamedani A, Anderson GH. Soy protein,
compared with casein based diets fed during gestation and lactation
increase food intake and risk of developing characteristics of metabolic syndrome in female rat offspring. Nutrients 2011; 31: 644–651.
21. Bautista CJ, Guzman C, Rodriguez-Gonzalez GL, Zambrano E.
Improvement in metabolic effects by dietary intervention is dependent on the precise nature of the developmental programming
challenge. J Dev Orig Health Dis 2015; 10: 1–8.

© 2017 The Authors
Obesity Science & Practice published by John Wiley & Sons Ltd, World Obesity and The Obesity Society. Obesity Science & Practice

232

Maternal proteins and metabolic syndrome

A. Jahan-mihan et al.

22. Jackson AA, Dunn RL, Marchand MC, Langley-Evans SC. Increased systolic blood pressure in rats induced by a maternal lowprotein diet is reversed by dietary supplementation with glycine.
Clin Sci (Lond) 2002; 103: 633–663.
23. Cherif H, Reusens B, Ahn MT, Hoet JJ, Remacle C. Effects of
taurine on the insulin secretion of rat fetal islets from dams fed a
low-protein diet. J Endocrinol 1998; 159: 341–348.
24. Korhonen H, Pihlanto A. Food-derived bioactive peptides – opportunities for designing future foods. Curr Pharm Des 2003; 9:
1297–1308.
25. Meisel H. Casokinins as bioactive peptides in the primary structure
of casein. In: Schwenke KD, Mothes R (eds). Food Proteins: Structure Functionality. VCH-Weinheim: New York, 1993, pp. 67–75.
26. Pupovac J, Anderson GH. Dietary peptides induce satiety via
cholecystokinin-A and peripheral opioid receptors in rats. J Nutr
2002; 132: 2775–2780. . [PubMed].
27. Daniel H, Vohwinkel M, Rehner G. Effect of casein and betacasomorphins on gastrointestinal motility in rats. J Nutr 1990; 120:
252–257. [PubMed].
28. Paroli E. Opioid peptides from food (the exorphins). World Rev Nutr
Diet 1988; 55: 58–97.
29. Boirie Y, Dangin M, Gachon P, Vasson MP, Maubois JL, Beaufrere
B. Slow and fast dietary proteins differently modulate postprandial
protein accretion. Proc Natl Acad Sci U S A 1997; 94:
14930–14935.
30. Dangin M, Boirie Y, Guillet C, Beaufrere B. Influence of the protein
digestion rate on protein turnover in young and elderly subjects. J
Nutr 2002; 132: 3228S–3233S.
31. Luiking YC, Deutz NE, Jakel M, Soeters PB. Casein and soy protein
meals differentially affect whole-body and splanchnic protein metabolism in healthy humans. J Nutr 2005; 135: 1080–1087.
32. Fukushima D. Soy Proteins. In: Yada RY (ed.). Proteins in Food
Processing. Woodhead Publishing: Cambridge, UK, 2004, pp.
100–122.
33. Shimizu M. Food-derived peptides and intestinal functions.
Biofactors 2004; 21: 43–47.
34. Yvon M, Beucher S, Guilloteau P, Le Huerou-Luron I, Corring T.
Effects of caseinomacropeptide (CMP) on digestion regulation.
Reprod Nutr Dev 1994; 34: 527–537.
35. FitzGerald RJ, Murray BA, Walsh DJ. Hypotensive peptides from
milk proteins. J Nutr 2004; 134: 980S–988S.
36. FitzGerald RJ, Meisel H. Milk protein-derived peptide inhibitors of
angiotensin-I-converting enzyme. Br J Nutr 2000; 84: S33–S37.
37. Meisel H. Biochemical properties of regulatory peptides derived
from milk proteins. Biopolymers 1997; 43: 119–128.
38. Nakamura T, Mizutani J, Sasaki K, et al. Beneficial potential of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro on central
blood pressure and hemodynamic index: a preliminary study. J Med
Food 2009; 12: 1221–1226.
39. Mizuno S, Nishimura S, Matsuura K, et al. Release of short and
proline-rich antihypertensive peptides from casein hydrolysate with
an Aspergillus oryzae protease. J Dairy Sci 2004; 87: 3183–3188.
40. Promintzer M, Krebs M. Effects of dietary protein on glucose homeostasis. Curr Opin Clin Nutr Metab Care 2006; 9: 463–468.
41. Akhavan T, Luhovyy BL, Brown PH, Cho CE, Anderson GH. Effect
of premeal consumption of whey protein and its hydrolysate on
food intake and postmeal glycemia and insulin responses in young
adults. Am J Clin Nutr 2010; 91: 966–975.
42. Bratusch-Marrain P, Bjorkman O, Hagenfeldt L, Waldhausl W,
Wahren J. Influence of arginine on splanchnic glucose metabolism
in man. Diabetes 1979; 28: 126–131.

Obesity Science & Practice

43. Floyd JC Jr, Fajans SS, Conn JW, Knopf RF, Rull J. Stimulation of
insulin secretion by amino acids. J Clin Invest 1966; 45:
1487–1502.
44. Roden M, Perseghin G, Petersen KF, et al. The roles of insulin and
glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest 1996; 97: 642–648.
45. Roy DM, Schneeman BO. Effect of soy protein, casein and trypsin
inhibitor on cholesterol, bile acids and pancreatic enzymes in mice.
J Nutr 1981; 111: 878–885.
46. Nitsan Z, Gertler A. The effect of methionine supplementation on
the levels of pancreatopeptidase E, trypsin, chymotrypsin and amylase in the pancreas of chicks receiving raw and heated soya-bean
diets. Br J Nutr 1972; 27: 337–342.
47. Forsen T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker
D. The fetal and childhood growth of persons who develop type 2
diabetes. Ann Intern Med 2000; 133: 176–182.
48. Jaquet D, Deghmoun S, Chevenne D, Collin D, Czernichow P, LevyMarchal C. Dynamic change in adiposity from fetal to postnatal life
is involved in the metabolic syndrome associated with reduced fetal
growth. Diabetologia 2005; 48: 849–855.
49. Yajnik C. Interactions of perturbations in intrauterine growth and
growth during childhood on the risk of adult-onset disease. Proc
Nutr Soc 2000; 59: 257–265.
50. Ekelund U, Ong KK, Linne Y, et al. Association of weight gain in
infancy and early childhood with metabolic risk in young adults. J
Clin Endocrinol Metab 2007; 92: 98–103.
51. Ong KK, Ahmed ML, Emmett PM, Preece MA, Dunger DB. Association between postnatal catch-upgrowth and obesity in childhood:
prospective cohort study. BMJ 2000; 320: 967–971.
52. Singhal A, Cole TJ, Fewtrell M, et al. Promotion of faster weight gain
in infants born small for gestational age: is there an adverse effect
on later blood pressure? Circulation 2007; 115: 213–220.
53. Soto N, Bazaes RA, Pena V, et al. Insulin sensitivity and secretion
are related to catch-up growth in small-for-gestational-age infants
at age 1 year: results from a prospective cohort. J Clin Endocrinol
Metab 2003; 88: 3645–3650.
54. Eriksson JG, Forsen T, Tuomilehto J, Osmond C, Barker DJ. Early
growth and coronary heart disease in later life: longitudinal study.
BMJ 2001; 322: 949–953.
55. Eriksson JG, Forsen T, Tuomilehto J, Osmond C, Barker DJ. Early
adiposity rebound in childhood and risk of type 2 diabetes in adult
life. Diabetologia 2003; 46: 190–194.
56. Eriksson JG, Osmond C, Kajantie E, Forsen TJ, Barker DJP. Patterns of growth among children who later develop type 2 diabetes
or its risk factors. Diabetologia 2006; 49: 2853–2858.
57. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ.
Weight in infancy and death from ischaemic heart disease. Lancet
1989; 2: 577–580.
58. Fabricius-Bjerre S, Jensen RB, Færch K, et al. Impact of birth
weight and early infant weight gain on insulin resistance and associated cardiovascular risk factors in adolescence. PLoS One 2011;
6: e20595.
59. Blumfield ML, Hure AJ, MacDonald-Wicks LK, et al. Dietary balance
during pregnancy is associated with fetal adiposity and fat distribution. Am J Clin Nutr 2012; 96: 1032–1041. . [CrossRef]
[PubMed.
60. Holzhauer S, Hokken Koelega AC, Ridder MD, et al. Effect of birth
weight and postnatal weight gain on body composition in early
infancy: the Generation R Study. Early Hum Dev 2009; 85:
285–290.

© 2017 The Authors
Obesity Science & Practice published by John Wiley & Sons Ltd, World Obesity and The Obesity Society. Obesity Science & Practice

